Tiffany Brown, Avobis Bio - Implantable Cell Therapy for Crohn's Fistulas | LSI USA '25

Avobis Bio is at the forefront of regenerative medicine, leveraging advanced biotechnologies to develop innovative therapeutics aimed at repairing and restoring damaged tissues and organs, thereby improving patient outcomes.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Tiffany Brown
Tiffany Brown
CEO, Avobis Bio